Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NutriBand (NTRB) Gains from Investment Securities (2018 - 2025)

NutriBand's Gains from Investment Securities history spans 8 years, with the latest figure at $409167.0 for Q4 2025.

  • For Q4 2025, Gains from Investment Securities fell 9.07% year-over-year to $409167.0; the TTM value through Oct 2025 reached $409167.0, down 9.07%, while the annual FY2025 figure was $689584.0, 21.18% down from the prior year.
  • Gains from Investment Securities for Q4 2025 was $409167.0 at NutriBand, down from $1.4 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $4.2 million in Q2 2024 and bottomed at $3331.0 in Q4 2021.
  • The 5-year median for Gains from Investment Securities is $409167.0 (2025), against an average of $677021.6.
  • The largest annual shift saw Gains from Investment Securities tumbled 96.26% in 2021 before it skyrocketed 13900.0% in 2024.
  • A 5-year view of Gains from Investment Securities shows it stood at $3331.0 in 2021, then surged by 3083.16% to $106031.0 in 2022, then skyrocketed by 65.83% to $175833.0 in 2023, then skyrocketed by 155.92% to $450000.0 in 2024, then decreased by 9.07% to $409167.0 in 2025.
  • Per Business Quant, the three most recent readings for NTRB's Gains from Investment Securities are $409167.0 (Q4 2025), $1.4 million (Q3 2025), and $1.4 million (Q2 2025).